This message was sent to ##Email##
|
|
|
|
|
| |
ADAA
April 5-8, 2018
Treatment-Resistance in Anxiety and Depression: Challenges and Opportunities
Washington Marriott Wardman Park Hotel
ADAA 2018 Opening Session and Keynote Address
Keynote:
Update from the NIMH
Thursday, April 5, 2018
5:45 - 7 p.m. (includes Q&A session)
Jerilyn Ross Lecture:
Pharmacological Strategies in the Treatment of Resistant Depression (TRD): The Past, The Present, and The Future
Friday, April 6, 2018
3:30 - 4:30 p.m. (includes Q&A session)
Learn more about the Keynote and Ross Lecture
2 Weeks Left to Submit Your 2018 Conference Abstract!
The submission deadline for presentations, workshops, roundtables, symposia, and the Ignite Symposia is Monday, Aug. 14. Submissions related to the theme of treatment-resistant depression, pharmacotherapy, complementary and alternative treatments, and all depression topics will be given preference.
Learn more about submission guidelines and submit today!
ADAA
The ADAA Scientific Council (SC) is comprised of mid- and senior-level basic and clinical researchers committed to the organization. The purpose of the SC is to contribute scientific expertise and mentorship, actively grow membership and encourage participation among colleagues, students and fellows, and volunteer to participate in projects that maintain ADAA's leading edge in research, dissemination, treatment and advocacy.
Meet the Scientific Council Chair:
Naomi Simon, MD, MSc, Chair
"I first joined ADAA in 1998 when I made the decision to build my career focused on anxiety and stress related disorders. It was clear ADAA was the premier professional organization in anxiety disorders. ADAA served as a welcoming, expert academic community with a broad focus on advancing research and clinical care, the career development of the next generation of clinicians and researchers, as well as the needs of patients and their families."
Dr. Simon recently joined NYU Langone to oversee its new Anxiety and Complicated Grief Program. Prior to joining NYU, Dr. Simon was a professor at Harvard Medical University School, Director of the Center for Anxiety & Traumatic Stress Disorders and Chief Medical Officer, Home Base, Red Sox Foundation and Massachusetts General Hospital. An undergraduate alumna of Brown University, Simon earned her medical degree from Harvard Medical School and her Master of Science degree in Psychiatric Epidemiology from Harvard School of Public Health. She completed a medical internship and residency at Columbia Presbyterian Hospital/New York Psychiatric Institute and fellowship training in Consultation Psychiatry at MGH. A prolific publisher of more than 170 peer reviewed manuscripts and book chapters, and a co-editor of two books in her field, Simon;s work has been reported in top peer-reviewed medical and psychiatric journals including Journal of the American Medical Association (JAMA), Biological Psychiatry and American Journal of Psychiatry. In addition, she serves as Associate Editor for a leading journal in her field, Depression and Anxiety.
She is a distinguished fellow of the American Psychiatric Association, a member of the American College of Neuropsychopharmacology, and a scientific advisor to the American Foundation for Suicide Prevention. Her research has been consistently funded by the National Institute of Health, the U.S. Department of Defense, Foundations, as well as by the nation's top pharmaceutical companies.
Meet the Scientific Council Vice Chair:
Doug Mennin, PhD
"I joined ADAA over 20 years ago after attending the conference my first year in grad school. I remember being struck at how much ADAA cared about understanding anxiety and helping those suffering about it. Their mission was clear and it seemed they wanted to do something to make a real difference. This initial observation is what I have observed time and again from ADAA. I have continued to be impressed over these many years. I feel lucky that I can now myself actively contribute to that multi-pronged mission and aid the organization in elucidating the science of anxiety and depression as well as providing my services to help ADAA get the word out to the public and improve the lives of those suffering from these conditions."
Professor Doug Mennin has developed an active program of research in clinical trials and basic research into the nature of chronic and recurring bouts of anxiety and mood disorders, particularly worry, stress, and depression. He has conducted numerous studies of the basic psychological and physiological mechanisms of generalized anxiety and depression and has recently been examining the role of worry and rumination in maintaining and exacerbating gastric dysfunction and chronic inflammation. He also regularly conducts psychotherapy outcome and mechanism research. Specifically, he has been examining Emotion Regulation Therapy (ERT), which is an integrative mind-body psychotherapy that draws from contemporary approaches as well as affect science and neuroscience. Professor Mennin’s work on ERT has demonstrated considerable positive outcomes as well as identified a number of cognitive, physiological, and neural mechanisms that may help explain how the therapy is effective. Along with colleagues at Memorial Sloan Kettering Cancer Center and in Denmark, he has also recently adapted this approach to treat distressed caregivers of patients with cancer.
Beginning in September 2017, Professor Mennin will become a Professor of Clinical Psychology at Teachers College, Columbia University. Professor Mennin received his Ph.D. from Temple University in 2001 and, has held previous positions in the Department of Psychology at New York University, Yale University, and, most recently, CUNY Hunter College where he has been a Professor of Psychology and Co-Director/Founder of the Health Psychology and Clinical Science Ph.D. training program.. In his academic role, Professor Mennin has trained numerous graduate students and post-baccalaureate research assistants on diagnosis, assessment, and treatment of anxiety and mood disorders. Professor Mennin has published over 100 articles, chapters, and books and regularly gives invited workshops and colloquia, and often speaks to the media about how to help people better understand and respond to their struggles with anxiety, worry, and depression. He currently serves on the editorial board of six journals and on the executive boards of the APA Division of Clinical Psychology and the Society for a Science of Clinical Psychology.
Interested in learning more about the Scientific Council and how you can become involved?
Please email Naomi Simon at Naomi.simon@nyumc.org or Douglas Mennin at dmennin@hunter.cuny.edu.
Interested in joining an ADAA Special Interest Group (SIG)? The Multicultural Advances SIG is seeking new members. The Multicultural Advances SIG encourages collaboration, communication, education, research, mentoring and networking focused on multicultural issues within anxiety, depression and related disorders. This SIG aims to facilitate increased attention on topics and issues concerning diversity and multiculturalism within ADAA and in the field in general, and encourages discussion, collaboration and research among researchers, clinicians and stakeholders interested in meeting the mental health needs of diverse underserved communities. Please contact Helen Heymann, ADAA Senior Education Program Manager to learn more.
ADAA
- Why do Birthdays Make People Anxious?, July 28, Refinery 29, Debra Kissen
- Take Your Traveling For Granted? Meet the People Who Can't, July 28, Boston Globe, Luana Marques and Eugenia Gorlin
- Can Antidepressant Medication Affect Your Running? July 24, Competitor.com, Simon Rego
- Why Does Being a Woman Put You at Greater Risk of Having Anxiety?, July 25, 2017, Science of Us, Michelle Craske
ADAA
Be There for Women Veterans in Your Community,
Dr. Megan McCarthy, Deputy Director, Suicide Prevention, VA Office of Mental Health and Suicide Prevention
ADAA
- Just Announced! Marketing Your Practice Online: Social Media and Beyond
Oct. 4 | Noon – 1 p.m. ET
Featuring: Helene Sobin, MBA and Rebecca Sachs, PhD, ABPP
 Ms. Sobin and Dr. Sachs will share insights on the importance of creating an online brand and presence, as well as strategies on how to effectively market your practice on-line.
Although social media can be an important component to promoting your practice, without a good brand identity and on-line presence it can be difficult to break through the clutter.
Learn about important actions you can take to strengthen your brand, clarify your message, and claim online profiles such as Healthgrades, Google My Business and Yelp. Ms. Sobin offers practice-building advice to mental health professionals and physicians throughout the country, providing her clients with customized marketing strategies that attract new patients and increase profitability. Dr. Sachs will describe her process in developing a strong brand with a clear target audience, with a consideration in balancing privacy, credibility, professionalism and personal style. She will discuss how she has used Twitter, Facebook and other online tools to enhance her reputation and increase referrals. We will review various social media channels, including LinkedIn, Facebook. Twitter and Instagram, and provide suggestions about which might be most relevant for clinicians. This webinar is not eligible for CEs.
-
Just announced! Personalized Medicine in Psychiatry on Management of Treatment- Resistant Depression
Oct. 18 | Noon – 1 p.m. ET
Featuring: Charles Nemeroff, MD, PhD
 This presentation will focus on the factors associated with treatment-resistance including a history of child abuse and neglect, prominent anxiety and certain comorbid medical and psychiatric conditions. The importance of accurate diagnosis will be highlighted including family history and evaluation for medical disorders associated with poor treatment response such as hypothyroidism and hypogonadism. Once a patient has failed an adequate trial of an antidepressant, a decision to either: 1) increase the dose of the current antidepressant, 2) engage in combination therapy of the current agent and another antidepressant or evidence-based psychotherapy (e.g. CBT), 3) utilize an augmentation strategy by adding an agent (e.g. lithium or T3) that is not an effective antidepressant, but when added to an antidepressant converts non-remitters to remitters, 4) switch to an entirely different antidepressant class, e.g. SSRI→SNRI or SSRI→MAOI 5) use a somatic non-pharmacological approach such as rTMS, VNS, or ECT. The evidence for these approaches will be summarized.
Finally, the status of experimental treatments including ketamine and DBS will be discussed. Eligible for 1 CE.
-
Just announced! PTSD: From Cells to Communities
Nov. 2 | Noon – 1 p.m. ET
Featuring: Dr. Kerry Ressler, MD, PhD
 PTSD is common, debilitating and poses a significant risk for suicide. Furthermore, while it is common in veterans, many are not aware of its prevalence in America's impoverished, urban neighborhoods that have high rates of violence. Several risk factors for the development of posttraumatic stress disorder in trauma survivors have been identified. These include severity and duration of the trauma, childhood abuse and neglect and lack of family or social support. Understanding the role of violence, poverty, and other components of high-risk environments is important for progress in stemming the cycles of risk in communities. Dr. Ressler will highlight recent progress in fear learning and memory, differential genetic susceptibility to disorders of fear, and how these findings are being applied to the understanding, treatment and possible prevention of fear disorders. Eligible for 1 CE.
-
How to Optimize Your Work with Immigrants In our Current Political Climate: 5 Tips for Successful Interventions
Sept. 14 | Noon – 1 p.m. ET
Featuring: Heidi Montoya, PhD
 This webinar will provide a brief overview of the stressors and mental health difficulties that immigration populations tend to experience and how the stressors have changed in light of the current sociopolitical climate. Additionally, strategies aimed at improving the care and wellbeing of immigrants will be reviewed. This webinar will also highlight harmful myths and erroneous beliefs about the immigration population in the U.S. This webinar is eligible for 1 CE.
-
OCD & Strategic Pressure: Working with Treatment Resistant Children & Adult Children Living @Home
Sept. 22 | Noon – 1 p.m. ET
Featuring:Jonathan Grayson, PhD
 This webinar will discuss identifying clients for whom Strategic Pressure (a treatment approach that can be used by therapists to work with the parents of treatment refusing children to pressure them into treatment) is suitable and how to educate your partners who are the parents of the treatment resistant/refusing child, in their new role. The steps to institute Strategic Pressure will be presented and illustrated with case illustrations. There are a number of phases in treatment from initial presentation to the gradual transition of the treatment refuser to a treatment user. This presentation will help therapists to navigate all of the pitfalls for each of these. Eligible for 1 CE.
Upcoming fall 2017 professional education webinars. Confirmed dates/times and registration information will be posted on the ADAA Professional Education Webinar website page as they are finalized.
- November 2 | Noon – 1 p.m. ET: PTSD: From Cells to Communities. Kerry Ressler, MD, PhD
- November 16 | Noon – 1 p.m. ET: Emotional Freedom Techniques. Joan Kaylor, MSEd, LPC, DCEP
- December 6 | Noon – 1 p.m. ET: How to Conquer Negative Thinking Habits and Depression Through CBT. Mary K. Alvord, PhD
- Fall/Winter 2017 | (Time TBA): Mining for Gold: How to Work Around Traditional Research Funding Sources by Using Crowdfunding and Novel Strategies to Get Your Work Funded.
Bruce Riser, PhD and Aaron Seitz, PhD
Webinar CE Information
- The Anxiety and Depression Association of America (ADAA) is approved by the American Psychological Association to sponsor continuing education credits for psychologists. ADAA maintains responsibility for this program and its contents. APA Approval Number: 739-26163171.
- ADAA SW CPE is recognized by the New York State Education Department's State Board for Social Work as an approved provider of continuing education for licensed social workers #0316.
- ADAA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6872. Programs that do not qualify for NBCC credit are clearly identified. ADAA is solely responsible for all aspects of the programs.
ADAA
Depression and Anxiety, the official journal of the Anxiety and Depression Association of America, is available online. ADAA members can subscribe at no charge. The journal welcomes original research and synthetic review articles covering neurobiology (genetics and neuroimaging), epidemiology, experimental psychopathology, and treatment (psychotherapeutic and pharmacologic) aspects of mood and anxiety disorders, and related phenomena in humans.
Learn more about the Journal
ADAA
Please find below a listing of upcoming two online courses and a conference offered by Massachusetts General Hospital Psychiatry Academy. MGHPA provides international leadership in education and dissemination of best practices in mental health. Utilizing the faculty and resources of the Massachusetts General Hospital Department of Psychiatry, they work with clinicians, departments, governments, and other entities to improve the mental health of patients worldwide through innovative teaching methods, technology, educational research, and institution level consultation. Use the code ADAA to save $50.
| | RESEARCH AND PRACTICE NEWS |
Psych Central
New research suggests that people with a family history of bipolar disorder may "age" more rapidly than those without a history of the disease. However, a common treatment for the disorder may conceal or even reverse the detrimental cellular effects. Investigators from King's College London research discovered that bipolar patients treated with lithium have longer telomeres compared to bipolar disorder patients not treated with lithium.
READ MORE
Intermountain Medical Center via EuerkAlert!
People who are diagnosed with coronary artery disease and then develop depression face a risk of death that's twice as high as heart patients without depression, according to a new study published July 28 in European Heart Journal - Quality of Care & Clinical Outcomes. The increased risk of death from any cause holds true whether the depression immediately follows the heart disease diagnosis or occurs even years later.
READ MORE
Medical News Today
Depression has been shown to alter the structure of the brain's white matter, which contains the circuitry that allows brain cells to communicate with each other, and which underpins brain function. So concludes a major study published in the journal Scientific Reports that used cutting-edge imaging technology to map the structure of white matter in the brains of more than 3,000 people.
READ MORE
TIME
Every week, when Ian Hanley sits down with his therapist, he goes through a list of depression treatments he's been researching online. The best-known treatments at the top of the list — half a dozen antidepressants and known combinations of those drugs — are all crossed out. "My therapist says he's never had this much difficulty with somebody," says Hanley, "which is sort of a dubious honor."
READ MORE
| |
MISSED AN ISSUE OF ANXIETY AND DEPRESSION INSIGHTS? VISIT AND SEARCH THE ARCHIVE TODAY. |
Psychiatry Advisor
Results published in PLoS One show an association between poor metabolic health and depression, regardless of weight status. Although obesity is often associated with metabolic syndrome (characterized by elevated blood glucose, blood pressure and cholesterol, for example), some obese individuals do not have these abnormalities, and thus are considered to have a metabolically healthy obese phenotype.
READ MORE
Psych Central
New research confirms the value of silently talking to yourself in the third person, especially during stressful times. The first-of-its-kind study discovered third person narrative self-talk helps one to control their emotions, and relatively effortlessly. The findings are published online in the journal Scientific Reports.
READ MORE
Psych Central
A population health study of very preterm and very-low-birth-weight individuals finds that these early births are not associated with anxiety and mood disorders later in life. The finding challenges earlier research that suggested increased risks. The study will appear in an upcoming issue of the Journal of Child Psychology and Psychiatry.
READ MORE
Medical News Today
We all get anxious from time to time, but what happens in the brain when this dreaded feeling looms? New research helps to answer this question. In a study of monkeys, a researcher discovered specific cells in the brain that are activated in response to anxiety. The findings are published in the journal Nature Communications.
READ MORE
Healthline
An FDA-approved therapy using magnetic stimulation on the brain can be given to people who haven’t responded well to antidepressants. When it comes to treating depression, it's tough to know what will work for specific people who have the condition. Antidepressants are commonly prescribed, but between 10 percent and 30 percent of people with major depression who take the medications fail to show improvement.
READ MORE
Quartz
Lately, the science has really been stacking up evidence against consuming sugars in excess. In a study published July 27 in Scientific Reports that followed over 8,000 adults over 22 years, researchers found that men who reported consuming foods that contained 67 grams of sugar per day or more were 23 percent more likely to be diagnosed with clinical depression after five years from when the study began.
READ MORE
Science Daily
A world-first systematic review into the safety of ketamine as a treatment for depression, published in the Lancet Psychiatry, shows the risks of long-term ketamine treatment remain unclear. Led by researchers from UNSW Sydney and Black Dog Institute, the review examined all prior published studies of ketamine treatment for depression, and finds few existing studies effectively report the safety of repeated doses or sustained use.
READ MORE
Science of Us
Right now, an estimated 18.1 percent of adults in the U.S. suffer from some form of anxiety disorder — going off of the most recent population count, that's more than 58 million Americans over the age of 18 who spend their days feeling constantly on edge, or living in fear of far-fetched health problems or other people, or waiting for the next panic attack to strike, or battling a constant, all-encompassing sense of worry.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
